Research ArticleArticle
Pharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant Tumors
R. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. Zucchetti
Drug Metabolism and Disposition December 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
R. Frapolli
E. Marangon
M. Zaffaroni
T. Colombo
C. Falcioni
R. Bagnati
M. Simone
M. D'Incalci
C. Manzotti
G. Fontana
P. Morazzoni
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Pharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant Tumors
R. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. Zucchetti
Drug Metabolism and Disposition December 1, 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Research ArticleArticle
Pharmacokinetics and Metabolism in Mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a New Oral C-seco-Taxane Derivative with Antiangiogenic Property Effective on Paclitaxel-Resistant Tumors
R. Frapolli, E. Marangon, M. Zaffaroni, T. Colombo, C. Falcioni, R. Bagnati, M. Simone, M. D'Incalci, C. Manzotti, G. Fontana, P. Morazzoni and M. Zucchetti
Drug Metabolism and Disposition December 1, 2006, 34 (12) 2028-2035; DOI: https://doi.org/10.1124/dmd.106.012153
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement